THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Increase (Decrease) in Accounts Payable, Trade
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported Increase (Decrease) in Accounts Payable, Trade of $19.79 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2024-11-20
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2024-09-30 was $51.25K, a 168.59% increase year-over-year.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2024-06-30 was -$9.34K.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2024-03-31 was -$22.11K.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2023-12-31 was $25.80K.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was -$1.74K, a 111.46% decline from fiscal 2022.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accounts payable, trade for fiscal 2022 was $15.17K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2024-09-30 | $51.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $41.90K derived: sum of 2 quarters · filed 2024-11-20 | $19.79K 10-Q · filed 2024-11-20 | $45.59K derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-06-30 | -$9.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$31.45K 10-Q · filed 2024-08-19 | -$5.66K derived: sum of 3 quarters · filed 2024-08-19 | $13.42K derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-03-31 | -$22.11K 10-Q · filed 2024-05-30 | $3.69K derived: sum of 2 quarters · filed 2024-05-30 | $22.77K derived: sum of 3 quarters · filed 2024-11-20 | -$13.56K derived: sum of 4 quarters · filed 2024-11-20 |
| 2023-12-31 | $25.80K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $44.88K derived: sum of 2 quarters · filed 2024-11-20 | $8.54K derived: sum of 3 quarters · filed 2024-11-20 | -$1.74K 10-K · filed 2024-04-17 |
| 2023-09-30 | $19.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | -$17.25K derived: sum of 2 quarters · filed 2024-11-20 | -$27.54K 10-Q · filed 2024-11-20 | |
| 2023-06-30 | -$36.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$46.62K 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | -$10.28K 10-Q · filed 2024-05-30 | |||
| 2022-12-31 | $15.17K 10-K · filed 2024-04-17 |